Betulinic Acid Modulates Redox Imbalance and Dysregulated Metabolisms, While Ameliorating Purinergic and Cholinergic Activities in Iron-Induced Neurotoxicity-Reference-Cited by-同舟云学术

Betulinic Acid Modulates Redox Imbalance and Dysregulated Metabolisms, While Ameliorating Purinergic and Cholinergic Activities in Iron-Induced Neurotoxicity

Published:2023-01-06 Issue:1 Volume:33 Page:198-207
ISSN:1981-528X
Container-title:Revista Brasileira de Farmacognosia
language:en
Short-container-title:Rev. Bras. Farmacogn.

Author:

Salau Veronica F.^ORCID,Erukainure Ochuko L.^ORCID,Ayeni Gideon^ORCID,Ibeji Collins U.^ORCID,Olasehinde Tosin A.^ORCID,Chukwuma Chika I.^ORCID,Koorbanally Neil A.^ORCID,Islam Md. Shahidul^ORCID

Funder

Inyuvesi Yakwazulu-Natali

National Research Foundation

Publisher

Springer Science and Business Media LLC

Subject

General Pharmacology, Toxicology and Pharmaceutics

Link

https://link.springer.com/content/pdf/10.1007/s43450-022-00349-4.pdf

Reference36 articles.

1. Ahmad A, Khan MM, Javed H (2012) Edaravone ameliorates oxidative stress associated cholinergic dysfunction and limits apoptotic response following focal cerebral ischemia in rat. Mol Cell Biochem 367:215–225. https://doi.org/10.1007/s11010-012-1335-6

2. Akomolafe S, Akinyemi A, Ogunsuyi O (2017) Effect of caffeine, caffeic acid and their various combinations on enzymes of cholinergic, monoaminergic and purinergic systems critical to neurodegeneration in rat brain—in vitro. Neurotoxicology 62:6–13. https://doi.org/10.1016/j.neuro.2017.04.008

3. Aswathy M, Vijayan A, Daimary UD, Girisa S, Radhakrishnan KV, Kunnumakkara AB (2022) Betulinic acid: a natural promising anticancer drug, current situation, and future perspectives. J Biochem Mol Toxicol 2022:e23206. https://doi.org/10.1002/jbt.23206

4. Bagatini MD, dos Santos AA, Cardoso AM, Mânica A, Reschke CR, Carvalho FB (2018) The impact of purinergic system enzymes on noncommunicable, neurological, and degenerative diseases. J Immunol Res 2018:4892473. https://doi.org/10.1155/2018/4892473

5. Chan CXa, Khan AA, Choi JH, Ng CD, Cadeiras M, Deng M, Ping P (2013) Technology platform development for targeted plasma metabolites in human heart failure. Clin Proteom 10:7. https://doi.org/10.1186/1559-0275-10-7

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Betulinic Acid for Glioblastoma Treatment: Reality, Challenges and Perspectives;International Journal of Molecular Sciences;2024-02-09